Cz Services, Inc. v. Anthem Insurance Companies, Inc. ( 2023 )


Menu:
  •                            NOT FOR PUBLICATION                           FILED
    UNITED STATES COURT OF APPEALS                        AUG 31 2023
    MOLLY C. DWYER, CLERK
    U.S. COURT OF APPEALS
    FOR THE NINTH CIRCUIT
    CZ SERVICES, INC., DBA Carezone                 No.    22-16504
    Pharmacy; CAREZONE PHARMACY,
    LLC,                                            D.C. No. 3:19-cv-04453-JD
    Plaintiffs-Appellants,
    MEMORANDUM*
    v.
    ANTHEM INSURANCE COMPANIES,
    INC.; PREMERA BLUE CROSS; BLUE
    CROSS AND BLUE SHIELD OF KANSAS
    CITY,
    Defendants-Appellees.
    Appeal from the United States District Court
    for the Northern District of California
    James Donato, District Judge, Presiding
    Argued and Submitted August 15, 2023
    Anchorage, Alaska
    Before: MURGUIA, Chief Judge, and PAEZ and NGUYEN, Circuit Judges.
    CZ Services, Inc. and CareZone Pharmacy, LLC (collectively, the
    “Pharmacies”) appeal the district court’s order dismissing this action for lack of
    personal jurisdiction over Anthem Insurances Companies, Inc., Blue Cross and
    *
    This disposition is not appropriate for publication and is not precedent
    except as provided by Ninth Circuit Rule 36-3.
    Blue Shield of Kansas City, and Premera Blue Cross (collectively, the “Insurers”)
    in the Northern District of California for violating California and Tennessee laws
    when Express Scripts, Inc. (“Express Scripts”), the Insurers’ pharmacy benefit
    manager, terminated the Pharmacies from its pharmacy network. We have
    appellate jurisdiction under 28 U.S.C § 1291. We review dismissal for lack of
    personal jurisdiction de novo and factual findings that underlie the jurisdictional
    determination for clear error. Freestream Aircraft (Berm.) Ltd. v. Aero L. Grp.,
    
    905 F.3d 597
    , 602 (9th Cir. 2018). We affirm.
    State law determines the bounds of personal jurisdiction, and California’s
    long-arm statute allows courts to exercise personal jurisdiction to the full extent
    permissible under the U.S. Constitution. Daimler AG v. Bauman, 
    571 U.S. 117
    ,
    125 (2014). Accordingly, this court “inquire[s] whether [the exercise of personal
    jurisdiction] comports with the limits imposed by federal due process.” 
    Id.
    For a court to exercise jurisdiction over a non-resident defendant, the
    defendant must “have certain minimum contacts . . . such that the maintenance of
    the suit does not offend traditional notions of fair play and substantial justice.”
    Williams v. Yamaha Motor Co. Ltd., 
    851 F.3d 1015
    , 1022 (9th Cir. 2017) (quoting
    Int’l Shoe Co. v. Washington, 
    326 U.S. 310
    , 316 (1945)). For a court to have
    specific jurisdiction over a defendant, two requirements must be satisfied: (1) the
    defendant must take “some act by which it purposefully avails itself of the
    2
    privilege of conducting activities within the forum State” and (2) the plaintiff’s
    claims “must arise out of or relate to the defendant’s contacts with the forum.”
    Ford Motor Co. v. Montana Eighth Jud. Dist. Ct., 
    141 S. Ct. 1017
    , 1024–25 (2021)
    (cleaned up). At issue is the second requirement. “Arise out of” requires
    “causation,” while “relate to” “contemplates that some relationships will support
    jurisdiction without a causal showing.” Id. at 1026. However, this “does not mean
    anything goes” as it concerns “relate to.” Id. “Relate to” continues to
    “incorporate[] real limits, as it must adequately protect defendants foreign to a
    forum.” Id.
    The injury the Pharmacies complain of—being terminated from Express
    Scripts’ pharmacy benefits network—is too attenuated to the Insurers’ contacts
    with California to maintain personal jurisdiction. Although the Insurers insure
    many members residing in California who the Pharmacies allege may have been
    affected by the termination, those contacts are related to the Insurers’ contacts with
    its members, not to the Insurers’ contacts with Express Scripts or with the
    Pharmacies themselves. These attenuated contacts do not meet the required “close
    connection” necessary to find specific jurisdiction. Yamashita v. LG Chem, Ltd.,
    
    62 F.4th 496
    , 506 (9th Cir. 2023).
    Additionally, we reject the Pharmacies’ argument that their claims “arise out
    of or relate to” the Insurers’ conduct in California because Express Scripts acted as
    3
    the Insurers’ agent. “Agency is the fiduciary relationship that arises when [a
    principal] manifests assent to [an agent] that the agent shall act on the principal’s
    behalf and subject to the principal’s conduct, and the agent manifests assent or
    otherwise consents so to act.” Am. Airlines, Inc. v. Mawhinney, 
    904 F.3d 1114
    ,
    1124 (9th Cir. 2018) (quoting Restatement (Third) Of Agency § 1.01 (2006)). “To
    establish an agency relationship, ‘[t]he principal must in some manner indicate that
    the agent is to act for him, and the agent must act or agree to act on his behalf and
    subject to his control.’” Id. (quoting Edwards v. Freeman, 
    212 P.2d 883
    , 884 (Cal.
    1949)).
    To establish an agency relationship, the Pharmacies point to provisions in
    the Insurers’ agreements with Express Scripts that allow Express Scripts to
    maintain and monitor networks on the Insurers’ behalf, give the Insurers’ limited
    ability to request pharmacies be added to or terminated from the network, or
    require written approval before Express Scripts makes material changes to the
    network. However, none of the contractual provisions that the Pharmacies rely on
    show that the Insurers had “the right to substantially control” Express Scripts’
    activities. Williams, 
    851 F.3d at 1025
    . Because Express Scripts was not acting as
    an agent of the Insurers when it terminated the Pharmacies from its network, there
    is no jurisdiction over the Insurers based on any agency relationship.
    AFFIRMED.
    4
    

Document Info

Docket Number: 22-16504

Filed Date: 8/31/2023

Precedential Status: Non-Precedential

Modified Date: 8/31/2023